1. Wilms’ tumor susceptibility: possible involvement of FOXP3 and CXCL12 genes
    Patricia Midori Murobushi Ozawa et al, 2016, Mol Cell Pediatr CrossRef
  2. Maraviroc decreases CCL8-mediated migration of CCR5+ regulatory T cells and reduces metastatic tumor growth in the lungs
    E. C. Halvorsen et al, 2016, OncoImmunology CrossRef
  3. Higher densities of Foxp3+ regulatory T cells are associated with better prognosis in triple-negative breast cancer
    Joe Yeong et al, 2017, Breast Cancer Res Treat CrossRef
  4. null
    Federica Riccardo et al, 2014 CrossRef
  5. Triple-negative breast cancer: New therapeutic options via signalling transduction cascades
    Ulrich Andergassen et al, 2017 CrossRef
  6. FOXP3 Is a HCC suppressor gene and Acts through regulating the TGF-β/Smad2/3 signaling pathway
    Jie-Yi Shi et al, 2017, BMC Cancer CrossRef
  7. Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer.
    Dariusz Waniczek et al, 2017, Arch Immunol Ther Exp (Warsz) CrossRef
  8. Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : a systematic review and meta-analysis
    Jiafeng Shou et al, 2016, BMC Cancer CrossRef
  9. The Clinicopathological and Prognostic Implications of FoxP3+ Regulatory T Cells in Patients with Colorectal Cancer: A Meta-Analysis.
    Peipei Xu et al, 2017, Front Physiol CrossRef
  10. Therapeutic blockade of Foxp3 in experimental breast cancer models.
    Mariela A Moreno Ayala et al, 2017, Breast Cancer Res Treat CrossRef
  11. Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma
    Hassan Sadozai et al, 2017, Front. Immunol. CrossRef
  12. The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC).
    Nobumoto Tomioka et al, 2018, Breast Cancer CrossRef
  13. An automated staining protocol for seven-colour immunofluorescence of human tissue sections for diagnostic and prognostic use
    Jeffrey Chun Tatt Lim et al, 2018, Pathology CrossRef
  14. Are rats more human than mice?
    Gerhild Wildner, 2018, Immunobiology CrossRef
  15. FoxP3 and IDO in Canine Melanocytic Tumors
    Ilaria Porcellato et al, 2018, Vet Pathol CrossRef
  16. Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis
    Qiaofen Fu et al, 2019, OncoImmunology CrossRef
  17. The predictive and prognostic value of FOXP3+/CD25+ regulatory T cells and PD-L1 expression in triple negative breast cancer
    Lin Zhang et al, 2019, Annals of Diagnostic Pathology CrossRef
  18. The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status
    Anna Glajcar et al, 2019, Virchows Arch CrossRef
  19. Breast Cancer Tumor Stroma: Cellular Components, Phenotypic Heterogeneity, Intercellular Communication, Prognostic Implications and Therapeutic Opportunities
    null Eiro et al, 2019, Cancers CrossRef
  20. The potential to target CCL5/CCR5 in breast cancer
    Marco Velasco-Velázquez et al, 2014, Expert Opinion on Therapeutic Targets CrossRef
  21. Emerging roles of regulatory T cells in tumour progression and metastasis
    Elizabeth C. Halvorsen et al, 2014, Cancer Metastasis Rev CrossRef
  22. The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis
    C. C. Engels et al, 2015, Breast Cancer Res Treat CrossRef
  23. Tumour-Infiltrating Lymphocytes (TILs) in Breast Cancer: a Predictive or a Prognostic Marker?
    Sathana Dushyanthen et al, 2015, Curr Breast Cancer Rep CrossRef
  24. The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis
    Shu Chen Lin et al, 2015, PLoS ONE CrossRef
  25. Foxp3-dependent transformation of human primary CD4+ T lymphocytes by the retroviral protein tax
    Li Chen et al, 2015, Biochemical and Biophysical Research Communications CrossRef
  26. Prognostic and predictive value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis
    X. Yu et al, 2016, Clin Transl Oncol CrossRef
  27. Clinicopathological and prognostic significance of FOXP3+ tumor infiltrating lymphocytes in patients with breast cancer: a meta-analysis
    Daqing Jiang et al, 2015, BMC Cancer CrossRef
  28. Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
    Koo Si-Lin et al, 2015, Curr Breast Cancer Rep CrossRef
  29. Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer
    Hirofumi Matsumoto et al, 2016, Breast Cancer Res Treat CrossRef
  30. The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis
    Yan Mao et al, 2016, PLoS ONE CrossRef
  31. Foxp3 overexpression in tumor cells predicts poor survival in oral squamous cell carcinoma
    Jing-Jing Song et al, 2016, BMC Cancer CrossRef
  32. The METINUS Plus method for nuclei quantification in tissue microarrays of breast cancer and axillary node tissue section
    Anna Korzynska et al, 2017, Biomedical Signal Processing and Control CrossRef
  33. Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer
    Mina Okabe et al, 2017, Cancer Sci CrossRef
  34. Differences in PD-L1–Expressing Macrophages and Immune Microenvironment in Testicular Germ Cell Tumors
    Sam Sadigh et al, 2019 CrossRef
  35. Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer
    Elie Dagher et al, 2020, Tumour Biol. CrossRef
  36. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
    Guoxuan Gao et al, 2020, BMC Cancer CrossRef
  37. Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?
    Triantafyllia Koletsa et al, 2020, Cancer Immunol Immunother CrossRef
  38. RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes
    María Sol Recouvreux et al, 2016, Oncotarget CrossRef
  39. Preoperative oral immunonutrition in gastrointestinal surgical patients: How the tumour microenvironment can be modified
    Alessia D'Ignazio et al, 2020, Clinical Nutrition ESPEN CrossRef
  40. Clustered nuclei splitting based on recurrent distance transform in digital pathology images
    Lukasz Roszkowiak et al, 2020, J Image Video Proc. CrossRef
  41. Prognostic Role of Immune Markers in Triple Negative Breast Carcinoma
    Hulya Sahin Ozkan et al, 2020, Pathol. Oncol. Res. CrossRef
  42. FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets
    Reem Saleh et al, 2020, Cancer Letters CrossRef
  43. null
    Ester Munera-Maravilla et al, 2020 CrossRef
  44. Assessment of stromal tumor infiltrating lymphocytes and immunohistochemical features in invasive micropapillary breast carcinoma with long-term outcomes
    Frederik Deman et al, 2020, Breast Cancer Res Treat CrossRef
  45. Immune microenvironment in different molecular subtypes of ductal breast carcinoma
    Mona Sadeghalvad et al, 2020, Breast Cancer Res Treat CrossRef
  46. Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
    Masanori Oshi et al, 2020, Cancers CrossRef
  47. Lifetime Genistein Intake Increases the Response of Mammary Tumors to Tamoxifen in Rats
    Xiyuan Zhang et al, 2017, Clin Cancer Res CrossRef
  48. The Multifaceted Role of Regulatory T Cells in Breast Cancer
    Kevin Kos et al, 2021, Annu. Rev. Cancer Biol. CrossRef
  49. Role of regulatory B cells in gastric cancer: Latest evidence and therapeutics strategies
    Yuanming Jing et al, 2021, International Immunopharmacology CrossRef
  50. Immune-related biomarkers in triple-negative breast cancer
    Juan Zhang et al, 2021, Breast Cancer CrossRef
  51. System for quantitative evaluation of DAB&H-stained breast cancer biopsy digital images (CHISEL)
    Lukasz Roszkowiak et al, 2021, Sci Rep CrossRef
  52. Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer
    Molly A. Nelson et al, 2021, Cancer Metastasis Rev CrossRef
  53. Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence
    Tracy Z Tien et al, 2021, Histopathology CrossRef
  54. Plasma level of prostate related‑antigen peptide‑reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccines
    Shuko Saku et al, 2021, Exp Ther Med CrossRef
  55. AKT1/FOXP3 axis-mediated expression of CerS6 promotes p53 mutant pancreatic tumorigenesis
    Dachuan Qi et al, 2021, Cancer Letters CrossRef
  56. Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Can Boost Immune Disruption
    Asmaa M Zahran et al, 2021, CMAR CrossRef
  57. Immunobiology of Melanoma
    Yee Peng Phoon et al, 2021, Clinics in Plastic Surgery CrossRef
  58. Tumor Microenvironment Mediators CD8+- and FOXP3+-Labeled T Lymphocytes Are Prospective Prognosticators in Curatively Treated Rectal Cancer Patients.
    Hala Zaghloul et al, 2021, J Gastrointest Cancer CrossRef
  59. Reduced infiltration of regulatory T cells in tumours from mice fed daily with gamma‐tocotrienol supplementa
    Shonia Subramaniam et al, 2021, Clin Exp Immunol CrossRef
  60. Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer
    Jianyu Liu et al, 2021, Front. Oncol. CrossRef
  61. Immunohistochemical expression of FOXP3 in gastric carcinoma; its relation to Ki-67 proliferation marker, HER2/neu expression, and other clinicopathological parameters
    Mona Y.Y. Abd-Allah et al, 2021, Journal of Immunoassay and Immunochemistry CrossRef
  62. ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma
    Weigang Qiu et al, 2022, Front. Oncol. CrossRef
  63. Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker
    Sadaf Qureshi et al, 2022, Biomark�Insights CrossRef
  64. Potential Predictive and Prognostic Value of Biomarkers Related to Immune Checkpoint Inhibitor Therapy of Triple-Negative Breast Cancer.
    Qiaorui Tan et al, 2022, Front Oncol CrossRef
  65. Transcriptional Dysregulation in Huntington’s Disease: The Role in Pathogenesis and Potency for Pharmacological Targeting
    Aleksandra Pogoda et al, 2021, CMC CrossRef
  66. Impact of FOXP3 gene polymorphisms and gene-environment interactions in asthma and atopy in a Brazilian population
    Cintia Rodrigues Marques et al, 2022, Gene CrossRef
  67. Human FOXP3 and tumour microenvironment
    Jia Wang et al, 2022, Immunology CrossRef
  68. Immune cells markers within local tumor microenvironment are associated with EBV oncoprotein in nasopharyngeal cancer
    Soehartati A. Gondhowiardjo et al, 2022, BMC Cancer CrossRef
  69. Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells
    Thomas Kolben et al, 2022, Cell Oncol. CrossRef
  70. Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment
    Sang Jun Han et al, 2022, Breast Cancer Res CrossRef
  71. The prognostic values of FOXP3+ tumor-infiltrating T cells in breast cancer: a systematic review and meta-analysis
    Yalan Sun et al, 2023, Clin Transl Oncol CrossRef
  72. Complexity and diversity of FOXP3 isoforms: Novel insights into the regulation of the immune response in metastatic breast cancer
    RamaRao Malla et al, 2023, International Immunopharmacology CrossRef
  73. Hedgehog Signaling Regulates Treg to Th17 Conversion Through Metabolic Rewiring in Breast Cancer
    Dominique C. Hinshaw et al, 2023 CrossRef
  74. Expression of FOXP3 of Tumor-Infiltrating Lymphocytes in Invasive Breast Cancer: Its Relationship to Histopathological Parameters and Overall Survival
    Swati Hagone et al, 2023, I.P. Pavlov Russian Medical Biological Herald CrossRef
  75. Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma
    James C. H. Chow et al, 2023, JAMA Netw Open CrossRef
  76. The role of immune modulatory CD163+ macrophages and FOXP3+ T regulatory lymphocytes in ulcerative colitis
    Laila M Farid et al, 2023, EGJP CrossRef
  77. Prognostic value and distribution pattern of tumor infiltrating lymphocytes and their subsets in distant metastases of advanced breast cancer
    Xin-yi Sun et al, 2023, Clinical Breast Cancer CrossRef
  78. Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00
    S Rusakiewicz et al, 2024, European Journal of Cancer CrossRef
  79. What is the relevance of FoxP3 in the tumor microenvironment and cancer outcomes?
    Abdo Meyiah et al, 2024, Expert Review of Clinical Immunology CrossRef